Pemetrexed Baxter Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Środki przeciwnowotworowe - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Ceplene Unjoni Ewropea - Pollakk - EMA (European Medicines Agency)

ceplene

laboratoires delbert - histaminy дигидрохлорид - białaczka, szpikowe, ostre - Иммуностимуляторы, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). skuteczność preparatu ceplene nie została w pełni wykazana u pacjentów w wieku powyżej 60 lat.

Bexon (50 mg + 50 mg + 0,5 mg)/ml Roztwór do wstrzykiwań Polonja - Pollakk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

bexon (50 mg + 50 mg + 0,5 mg)/ml roztwór do wstrzykiwań

aflofarm farmacja polska sp. z o.o. - thiamini hydrochloridum + pyridoxini hydrochloridum + cyanocobalaminum - roztwór do wstrzykiwań - (50 mg + 50 mg + 0,5 mg)/ml